Soleus Capital Management »

Corcept Therapeutics Incorporated shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $12M 286k 40.31
2021-09-30 $3.0M 155k 19.68

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Celcuity (CELC)
Tg Therapeutics (TGTX)
Insulet Corporation (PODD)
Novocure Ord Shs (NVCR)
United Therapeutics Corporation (UTHR)
Praxis Precision Medicines I Com New (PRAX)
Vericel (VCEL)
Alkermes SHS (ALKS)
Biosante Pharmaceuticals (ANIP)
Globus Med Cl A (GMED)
Geron Corporation (GERN)
Twist Bioscience Corp (TWST)
Edgewise Therapeutics (EWTX)
Beta Bionics (BBNX)

View all positions for Soleus Capital Management

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Vanguard Portfolio Management
Vanguard Capital Management
Parallel Advisors
State Street Corporation
Geode Capital Management
FMR
First Trust Advisors
Dimensional Fund Advisors
Tang Capital Management
Caption Management
UBS Group

View all funds holding Corcept Therapeutics Incorporated